List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 19 studies with search of: "ZIOPHARM" [Exact]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Phase 1 Study of ZIO-201-T in Combination With Doxorubicin in Solid Tumors
Condition: Advanced Cancer
Intervention: Drug: ZIO-201-T and doxorubicin
2 Completed A Phase-II Trial of ZIO 101 in Advanced Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Intervention: Drug: Darinaparsin
3 Suspended Study of Oral Palifosfamide Tris in Solid Tumors
Condition: Advanced Cancer
Intervention: Drug: oral palifosfamide tris
4 Active, not recruiting Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow Cancers
Conditions: Hematologic Neoplasms;   Bone Marrow Neoplasms;   Non-Hodgkin's Lymphoma
Intervention: Drug: Darinaparsin
5 Active, not recruiting Phase I Study of Oral ZIO-101 in Advanced Solid Tumors
Condition: Advanced Cancer
Intervention: Drug: Darinaparsin
6 Active, not recruiting A Protocol for the Safety and Tolerance of Intravenous Isophosphoramide Mustard (IPM) in Patients With Advanced Cancer
Condition: Advanced Cancer
Intervention: Drug: ZIO-201
7 Active, not recruiting Phase I Study of Indibulin in Patients With Solid Tumors
Condition: Solid Tumors
Intervention: Drug: indibulin
8 Active, not recruiting A Phase II Trial of ZIO-101 in Advanced Multiple Myeloma: Protocol SGL2001b
Condition: Multiple Myeloma
Intervention: Drug: Darinaparson
9 Active, not recruiting A Phase I Trial of ZIO-101 in Hematologic Cancers
Conditions: Acute Leukemia;   Chronic Myeloproliferative Disease;   Chronic Lymphoproliferative Disease;   Multiple Myeloma;   Lymphoma;   Poor-Risk Myelodysplasia (MDS)
Intervention: Drug: Darinaparsin
10 Active, not recruiting Phase I Study of Oral ZIO-101-C in Advanced Solid Tumors and Lymphomas
Conditions: Advanced Solid Tumors;   Lymphomas
Intervention: Drug: ZIO-101-C (Darinaparsin)
11 Recruiting Phase I Study of Indibulin in Combination With Erlotinib in Advanced Solid Tumors
Condition: Advanced Solid Tumors
Interventions: Drug: indibulin;   Drug: erlotinib
12 Recruiting A Study of Palifosfamide Tris Plus Doxorubicin Versus Doxorubicin in Unresectable or Metastatic Soft-Tissue Sarcoma
Condition: Soft Tissue Sarcoma
Interventions: Drug: Palifosfamide Tris and Doxorubicin;   Drug: Doxorubicin
13 Active, not recruiting Study of ZIO-201 in Advanced Sarcoma
Condition: Advanced Sarcoma
Intervention: Drug: ZIO-201
14 Recruiting Phase 1b Study of Indibulin in Combination With Capecitabine in Advanced Solid Tumors
Condition: Advanced Solid Tumors
Interventions: Drug: indibulin;   Drug: capecitabine
15 Recruiting Phase IB Study of Indibulin Using Positron-Emission Tomography (PET) Scans
Condition: Advanced Cancer
Intervention: Drug: indibulin
16 Recruiting Phase I Study in Advanced Solid Tumors
Condition: Solid Tumors
Intervention: Drug: indibulin
17 Active, not recruiting A Phase I Trial of ZIO-101 in Solid Tumors
Condition: Solid Tumors
Intervention: Drug: Darinaparsin
18 Active, not recruiting Study of ZIO-101 in Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Darinaparsin
19 Completed Phase I Trial of ZIO-101 in Patients With Solid Tumors
Condition: Solid Tumors
Intervention: Drug: ZIO-101

Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services